[131I]iodoazomycin arabinoside (cas 138172-12-0) for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice

Add time:08/18/2019    Source:sciencedirect.com

BackgroundThe preliminary characterization of [131I]iodoazomycin arabinoside ([131I]IAZA) as a potential radiotherapeutic radiopharmaceutical is described.

We also recommend Trading Suppliers and Manufacturers of iodoazomycin arabinoside (cas 138172-12-0). Pls Click Website Link as below: cas 138172-12-0 suppliers

Prev:Original ArticlesSynthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside (cas 138172-12-0)
Next:Synthesis of C-glycosylated amino acids by hetero-Diels–Alder addition of ethyl 2-nitrosoacrylate to exo-glycals)